INDEX. 783 



PAGE 



action, 142 ; phallin. 428 ; of pollens, 426 ; precipi- 

 tation of, 177; preparation, 177; properties of, 176, 

 352 ; as receptors of, second order, 351 ; ricin, 427 ; 

 robin, 427 ; secondary or adventitious, 178 ; toxin 

 spectrum, 194, 353 ; standardization of, 183 ; staph- 

 ylolysin, 538 ; structure, 191 ; tpxophores, 193, 353 ; 

 see side-chain theory ; union with tissue cells, 177, 

 200, 344, 348, 366, 368. 415 ; vegetable, 21, 425- 

 428 ; see individual micro-organisms. 



Toxoids 193-196, 353 



Toxon 195, 35, 406 



Toxophorous group, toxophore 193, 351 



Trichomonax iittcstinalis, morphology and pathogenicity 



of 693, o94 



TricJionionas rtif/inalis 693 



Trichophyton 640 



Tritotoxin 196, 353 



Trypanosoma 670 



Agglutination of. 671 ; cultivation of, 679, 681 ; mor- 

 phology of, 670 ; multiplication of, 671 ; rosette 

 formation by, 671 ; sleeping sickness, 673 ; species 

 of, 670, 671, 677 ; trypanosomatic fever, 673. 



Trypanosomatic fever 673 



Sleeping sickness, relation to, 673, 674 ; symptoms 

 of, 674 ; trypanosomes in, 674. 



Trypanosomiasis 670-684 



Agglutination reactions, 684 ; immunity and suscepti- 

 bility, 683 ; in man, 673-677 ; parasites, occurrence 

 of in the blood, 678 ; serotherapy of, 684 ; "trypan- 

 roth" in treatment of, 684 ; vaccination in, 683 ; 

 see Sleeping sickness and Trypanosomatic fever. 



Trypanosomiasis in animals 678-683 



Dourine, 682 ; horses, cattle and mules. 680-683 ; mal 

 de cederas, 682 ; nagana, 680 ; in rats, 679 ; surra, 

 681 ; symptomatology, 678. 



"Trypanroth" in treatment of trypanosomiasis. .. .683, 684 

 Tsetse flies, in transmission of trypanosomiasis ; see 

 Trypanosomiasis. 



Tuberculin of Koch and others 363, 364, 578, 579, 580 



Dangers, errors and limitations in use, 601, 602 ; 

 diagnostic use of. 599-603, 612 ; disturbances caused 

 by, 599 ; immunization with, 577, 598, 599 ; prepa- 

 ration of. 578 ; principles of action. 606 ; specificity 

 of, 601. 602 ; standardization of, 578, 580 ; therapy, 

 602, 603. 



Tuberculocidin 580 



Tuberculosis 25, 573-615 



Agglutination as an index of immunity to, 607 ; ag- 

 glutination reaction, 607. 610 ; amyloid degeneration 

 in, 591 ; "anatomic tubercle," 585 ; in animals, 593, 

 611 ; avian, 612; bovine, 611 ; bovine, relation of, to 

 human, 582, 583 ; congenital, 584 ; disinfection in, 

 593 ; dissemination by means of phagocytes, 588 ; 

 "droplet infection." 585 ; "dust infection,' 585 ; 

 healing, spontaneous. 587 ; heredity in, 596 ; immu- 

 nity and susceptibility. 128, 130, 169, 593, 597, 599, 

 607 ; immunization, mixed. 609 ; infection atria, 585, 

 586 ; infectiveness of, 573 ; latent, 584 ; lupus yul- 

 garis, 585 ; metastases in, 586 ; miliary. 587 : mixed 

 infections in, 591 ; organs attacked, 585, 586 ; pha- 

 gocytosis, 588 ; pneumonia during, 510 ; predispos- 

 ing factors to. 595 ; primary and secondary, 587 ; 

 prophylaxis, 592, 593 ; pulmonary, 585 ; sero- 



